Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 ml) is still effective
- 23 January 2009
- journal article
- research article
- Published by Springer Nature in Heart and Vessels
- Vol. 24 (1) , 27-31
Abstract
Echo-guided alcohol septal ablation (ASA) is an alternative treatment for highly symptomatic patients with obstructive hypertrophic cardiomyopathy (HOCM). Previous reports suggest that a low dose of alcohol (1.5–2 ml) is as effective as the classic dose (2–4 ml) used in the past. Because a larger infarct might be associated with a potential long-term risk, in this pilot study we wanted to determine whether an ultra-low dose of alcohol (1 ml) would be effective in the mid-term follow-up. Seventy patients (55 ± 13 years, range 24–81 years, septum thickness P < 0.01, and 2.5 ± 0.7 vs 1.4 ± 0.4 NYHA class for group II; P < 0.01) and angina (2.1 ± 1 vs 0.6 ± 0.8 Canadian Cardiovascular Society [CCS] class for group I; P < 0.01, and 2.1 ± 0.9 vs 0.7 ± 0.7 CCS class for group II; P < 0.01). There was a significant decrease in left ventricular (LV) ejection fraction (P < 0.05), septum thickness (P < 0.01), and LV outflow gradient (P < 0.01) in both groups of patients. However, there was no significant difference with regard to the extent of symptomatic or echocardiographic changes and complications between both groups. These results suggest that the ultra-low dose of alcohol (1 ml) is still effective in the treatment of the majority of HOCM patients without extreme septum hypertrophy (<31 mm).Keywords
This publication has 23 references indexed in Scilit:
- Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathyHeart and Vessels, 2007
- Surgery Insight: septal myectomy for obstructive hypertrophic cardiomyopathy—the Mayo Clinic experienceNature Clinical Practice Cardiovascular Medicine, 2007
- Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.2007
- The "1st septal unit" in hypertrophic obstructive cardiomyopathy: a newly recognized anatomo-functional entity, identified during recent alcohol septal ablation experience.2007
- Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A Systematic Review of Published StudiesJournal of Interventional Cardiology, 2006
- Early Onset and Progression of Left Ventricular Remodeling After Alcohol Septal Ablation in Hypertrophic Obstructive CardiomyopathyCirculation, 2005
- Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: How much alcohol should be injected?Catheterization and Cardiovascular Interventions, 2005
- Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changesThe American Journal of Cardiology, 2005
- Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathyThe Lancet, 1995
- A large conus artery in patients with hypertrophic cardiomyopathyHeart and Vessels, 1992